The Effect of Modified Si Ni Fu Mai Decoction Combined with Ear Acupressure on Elderly Patients with Atrial Fibrillation and Anxiety
Abstract
Methods: A total of 40 elderly patients with atrial fibrillation and anxiety were clinically collected and randomly grouped into a control group
and an observation group. All patients received sustained-release metoprolol succinate tablets to control heart rate and rivaroxaban tablets for
anticoagulant therapy. In the control group, patients additionally used flupentixol and melitracen tablets; while the observation group applied
modified Si Ni Fu Mai Decoction on this basis, combined with ear acupressure therapy. The entire treatment process lasted for four weeks,
observing two treatment cycles. During this period, the changes in Traditional Chinese medicine syndrome scores, Hamilton Anxiety Scale
(HAMA) scores, and European Quality of Life Five Dimensions Five Levels Scale (EQ-5D-5L) scores before and after treatment were assessed and compared between the two groups; adverse reactions were also recorded. Results: After treatment, both groups showed significant
reductions in Traditional Chinese medicine syndrome scores, HAMA scores, and EQ-5D-5L scores, with the improvement in the observation
group being significantly better than that in the control group, and the differences were statistically significant (P<0.01). The total effective
rate of improvement in Traditional Chinese medicine symptoms in the observation group was 94.44%, significantly higher than 52.62% in
the control group; the total effective rate for anxiety symptoms was 88.99%, markedly higher than 42.11% in the control group; the clinical total effective rate of electrocardiogram was 77.78%, significantly better than 26.32% in the control group; all these differences were
statistically significant (P<0.01). In terms of adverse reactions, no significant differences were observed between the two groups (P>0.05).
Conclusion: The use of modified Si Ni Fu Mai Decoction combined with ear acupressure therapy demonstrates significant clinical efficacy in
improving anxiety states, negative emotions, and quality of life in elderly patients with atrial fibrillation.
Keywords
Full Text:
PDFReferences
[1] China Cardiovascular Health and Disease Report 2021 Summary [J]. China Circulation Journal, 2022, 37(06):553-578.
[2] Ma C. Epidemiological Advances in Atrial Fibrillation [J]. Medicine and Philosophy, 2016, 37(22):7-9, 26.
[3] Kirchhof P, Benussi S, Kotecha D, et al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with
EACTS[J]. European Heart Journal, 2016, 37(38):2893-2962.
[4] Huang Congxin, Zhang Shu, Huang Dejia, et al. Atrial fibrillation: Current understanding and treatment recommendations-2018 [J].
China Journal of Cardiac Pacing and Electrophysiology, 2018, 32(04):315-368.
[5] Zhou Zhongying. Internal Medicine of Traditional Chinese Medicine [M]. 2nd ed. Beijing: China Traditional Chinese Medicine Press,
2007:130-131.
[6] Zheng Xiaoyu. Clinical Research Guidelines for New Traditional Chinese Medicine Drugs (Trial) [M]. 1st ed. Beijing: China Medical
Science and Technology Press, 2002:77-85.
[7] Tan C. Interpretation of the 2020 ECS/EACTS Guidelines for the Diagnosis and Management of Atrial Fibrillation [J]. China Journal of
Evidence-Based Cardiovascular Medicine, 2021, 13(02):129-132.
[8] Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries[J]. Int J
Cardiol, 2013, 167(6): 2412-2420.
[9] Liu Xueyan, Yang Ping. Psychological and mental disorders in atrial fibrillation the "dual-heart" proposition that cannot be ignored [J].
China Journal of Clinical Physicians, 2016, 44(08):10-13.
[10] Sang CH, Chen K, Pang XF, et al. Depression, anxiety, and quality of life in patients with atrial fibrillation[J]. Clin Cardiol, 2013, 36(1):
40-45.
[11] Deng P, Hu D, Xu R, Liu YW, Liu ZY. Liu ZY's "Dual-Heart Synergy" Theory in the Treatment of Arrhythmia [J]. World Journal of Integrative Medicine, 2017, 12(11):1509-1512+1520.
DOI: http://dx.doi.org/10.70711/pmr.v3i4.8813
Refbacks
- There are currently no refbacks.
